Abstract
A growing body of work shows that autonomic signals provide a privileged evidence-stream to capture various aspects of subjective and neural states. This work investigates the potential for autonomic markers to track the effects of psychedelics — potent psychoactive drugs with important scientific and clinical value. For this purpose, we introduce a novel Bayesian framework to estimate the entropy of heart rate dynamics under psychedelics. We also calculate Bayesian estimates of mean heart rate and heart rate variability, and investigate how these measures relate to subjective reports and neural effects. Results on datasets covering four drugs — lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), psilocybin, and sub-anaesthetic doses of the dissociative agent ketamine — show consistent increases in mean heart rate, high-frequency heart rate variability, and heart rate entropy during the psychedelic experience. Moreover, these effects have predictive power over various dimensions of the psychedelic experience. Changes in heart rate entropy were found to be correlated with increases in brain entropy, while other autonomic markers were not. Overall, our results show that a cost-efficient autonomic measure has the potential to reveal surprising detail about subjective and brain states, opening up a range of new research avenues to explore in both basic and clinical neuroscience.
Introduction
While psychedelic research has expanded significantly, most studies focus on neural activity via fMRI or EEG. It is well-established that psychedelics increase "brain entropy"—a state of more diverse and less predictable neural activity that correlates with the richness of subjective experience. However, the physiological "body" side of this equation is often overlooked or simplified to basic metrics like heart rate. Standard autonomic measures, such as basic Heart Rate Variability (HRV), are frequently too coarse to capture the non-linear dynamics of the heart under the influence of potent psychoactive substances. This study addresses this gap by investigating whether the heart mirrors the brain's entropic shift and if cost-efficient autonomic monitoring can track the psychedelic state.
Methodology and Datasets
The researchers developed a two-step Bayesian pipeline to analyze heart rate dynamics:
- Bayesian Heart Rate Estimation: A state-space model was used where the "true" heart rate is a hidden process driving observed beats. Markov chain Monte Carlo (MCMC) sampling generated 500 heart rate trajectories per subject to capture uncertainty.
- Entropy via Context Tree Weighted (CTW) Algorithm: Complexity was measured using the CTW algorithm, allowing for "cross-entropy" estimation. This compared drug-session data against a subject's placebo baseline to identify diverging patterns.
- Derivative-based Binarization: To account for non-stationary data, the signal was binarized based on the sign of the derivative (increasing vs. decreasing HR).
The study utilized four distinct datasets: LSD (N=20), DMT (N=13), Psilocybin (N=15), and Ketamine (N=19).
Results: Consistent Autonomic Shifts
Across all four substances—LSD, DMT, psilocybin, and ketamine—significant increases were observed in mean heart rate, high-frequency HRV (parasympathetic activity), and heart rate entropy compared to placebo.
Notably, the researchers identified a "joy" profile: a simultaneous increase in mean heart rate, high-frequency HRV, and entropy. This pattern is rare, as sympathetic activation (increased HR) typically decreases HRV. This specific profile has been previously associated with positive emotional states.
The Heart-Brain Mirror and Subjective Tracking
A key finding of this study is that changes in heart rate entropy significantly correlate with changes in brain entropy. In the DMT dataset, heart rate entropy changes explained up to 70% of the between-subjects variance in brain entropy at peak drug effects. This suggests that the "entropic brain" hypothesis may be part of a broader "entropic organism" phenomenon.
Furthermore, autonomic markers showed high predictive power for subjective reports. Mean heart rate was a strong predictor of overall experience intensity, while heart rate entropy was more effective at predicting "challenging" experiences or the presence of complex visual imagery.
Discussion
While these results establish a strong correlation, the direction of causality remains to be determined—whether the brain drives the heart, the heart drives the brain via interoception, or the drug acts on both simultaneously. Despite small sample sizes typical of clinical psychedelic research, the consistency across four different drugs is robust. These findings suggest that cost-efficient autonomic markers could be used for real-time monitoring in psychedelic-assisted therapy, providing therapists with insights into a patient's state without the need for expensive neuroimaging equipment.
Summary updated